U.S. FDA Guidance Clarifies GMPs for Combo Products

The GMP Letter
A A
In a 46-page draft guidance released Jan. 26, the U.S. FDA clarified a 2013 final rule that specifies how combination product manufacturers should meet both device and drug quality regulations and implement streamlined quality systems.

To View This Article:

Login

Subscribe To The GMP Letter